Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer
Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer
Not yet recruiting · NCT07041437 · Registry updated 2025-06-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer | Advanced Breast Cancer | Not yet recruiting | Phase 2 | 2025-06-27 | NCT07041437 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan Cancer Hospital | Shanghai | China | 4 |